Main competitors
P/E (Y) Price to Book (Y) PEG (Y) EV / Sales (Y) EV / EBITDA (Y) EV / EBIT (Y) Dividend Yield (Y) Capi.($)
-2.81x1.02x0.05x - -0.85x-0.88x - 164M
17.18x1.67x-0.76x3.31x9.91x11.32x0.56% 53.86B
47.39x5.12x-2.49x8.1x34.99x36.87x-.--% 33.16B
16.03x2.8x0.64x3.81x10.43x12.2x1.81% 26.05B
-22.91x1.23x-0.5x5.59x-9.1x-7.81x-.--% 26.23B
-19.31x95.11x4.24x42.97x-21.13x-20.86x-.--% 19.5B
-48.3x - -1.67x - -48.43x-47.6x-.--% 15.27B
13.34x2.04x-0.89x2.54x7.27x7.78x-.--% 13.11B
22.89x1.89x0.98x3.99x11.57x14.82x-.--% 12.49B
18.01x3.95x0.66x4.19x11.99x13.02x-.--% 11.01B
1638.1x10.85x-15.1x20.55x234.88x1029.02x-.--% 10.44B
-108.98x23.46x-0.84x33.64x-186.73x-103.52x-.--% 9.38B
183.5x - -1.48x20.15x - 195.48x - 8.6B
-33.22x6.31x-5.04x5.61x-47.8x-38.58x-.--% 6.27B
-22.38x12.12x0.54x8.59x-15.21x-17.47x-.--% 6.34B
29.7x5.29x0.3x9.63x27.32x29.2x0.89% 5.87B
23.3x5.99x0.94x - - - - 5.8B
-15.15x6.08x-0.58x - -16.13x-13.96x-.--% 5.39B
53.53x1.83x-2.39x3.41x15.5x28.08x0.36% 5.41B
Average 94.21x 10.99x -1.23x 11.74x 1.09x 62.62x 0.23% 14.44B
Weighted average by Cap. 71.74x 11.47x -0.98x 10.21x 5.42x 46.88x 0.32%
Bio Therapeutic Drugs